Literature DB >> 15192093

Identification of domain structures in the propeptide of corin essential for the processing of proatrial natriuretic peptide.

Sabine Knappe1, Faye Wu, Mary Rose Madlansacay, Qingyu Wu.   

Abstract

Corin is a type II transmembrane serine protease and functions as the proatrial natriuretic peptide (pro-ANP) convertase in the heart. In the extracellular region of corin, there are two frizzled-like cysteine-rich domains, eight low density lipoprotein receptor (LDLR) repeats, a macrophage scavenger receptor-like domain, and a trypsin-like protease domain at the C terminus. To examine the functional importance of the domain structures in the propeptide of corin for pro-ANP processing, we constructed a soluble corin, EKshortCorin, that consists of only the protease domain and contains an enterokinase (EK) recognition sequence at the conserved activation cleavage site. After being activated by EK, EKshortCorin exhibited catalytic activity toward chromogenic substrates but failed to cleave pro-ANP, indicating that certain domain structures in the propeptide are required for pro-ANP processing. We then constructed a series of corin deletion mutants and studied their functions in pro-ANP processing. Compared with that of the full-length corin, a corin mutant lacking frizzled 1 domain exhibited approximately 40% activity, whereas corin mutants lacking single LDLR repeat 1, 2, 3, or 4 had approximately 49, approximately 12, approximately 53, and approximately 77% activity, respectively. We also made corin mutants with a single mutation at a conserved Asp residue that coordinates Ca(2+)-binding in LDLR repeats 1, 2, 3, or 4 (D300Y, D336Y, D373Y, and D410Y) and showed that these mutants had approximately 25, approximately 11, approximately 16, and approximately 82% pro-ANP processing activity, respectively. Our results indicate that frizzled 1 domain and LDLR repeats 1-4 are important structural elements for corin to recognize its physiological substrate, pro-ANP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192093     DOI: 10.1074/jbc.M405041200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  Human corin isoforms with different cytoplasmic tails that alter cell surface targeting.

Authors:  Xiaofei Qi; Jingjing Jiang; Mingqing Zhu; Qingyu Wu
Journal:  J Biol Chem       Date:  2011-04-25       Impact factor: 5.157

2.  Effect of sialylated O-glycans in pro-brain natriuretic peptide stability.

Authors:  Jingjing Jiang; Nicole Pristera; Wei Wang; Xiumei Zhang; Qingyu Wu
Journal:  Clin Chem       Date:  2010-03-26       Impact factor: 8.327

Review 3.  The cutting edge: membrane-anchored serine protease activities in the pericellular microenvironment.

Authors:  Toni M Antalis; Marguerite S Buzza; Kathryn M Hodge; John D Hooper; Sarah Netzel-Arnett
Journal:  Biochem J       Date:  2010-06-15       Impact factor: 3.857

4.  Ectodomain shedding and autocleavage of the cardiac membrane protease corin.

Authors:  Jingjing Jiang; Shannon Wu; Wei Wang; Shenghan Chen; Jianhao Peng; Xiumei Zhang; Qingyu Wu
Journal:  J Biol Chem       Date:  2011-02-02       Impact factor: 5.157

5.  The serine protease Corin is a novel modifier of the Agouti pathway.

Authors:  David Enshell-Seijffers; Catherine Lindon; Bruce A Morgan
Journal:  Development       Date:  2007-12-05       Impact factor: 6.868

6.  Corin, atrial natriuretic peptide and hypertension.

Authors:  Yiqing Zhou; Jingjing Jiang; Yujie Cui; Qingyu Wu
Journal:  Nephrol Dial Transplant       Date:  2009-01-07       Impact factor: 5.992

Review 7.  Corin in natriuretic peptide processing and hypertension.

Authors:  Yiqing Zhou; Qingyu Wu
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 8.  Membrane-anchored serine proteases in vertebrate cell and developmental biology.

Authors:  Roman Szabo; Thomas H Bugge
Journal:  Annu Rev Cell Dev Biol       Date:  2011-06-29       Impact factor: 13.827

9.  Corin variant associated with hypertension and cardiac hypertrophy exhibits impaired zymogen activation and natriuretic peptide processing activity.

Authors:  Wei Wang; Xudong Liao; Koichi Fukuda; Sabine Knappe; Faye Wu; Daniel L Dries; Jun Qin; Qingyu Wu
Journal:  Circ Res       Date:  2008-07-31       Impact factor: 17.367

Review 10.  Natriuretic peptides and the genomics of left-ventricular hypertrophy.

Authors:  Daniel L Dries
Journal:  Heart Fail Clin       Date:  2010-01       Impact factor: 3.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.